BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 26097581)

  • 1. Prognostic significance of phosphorylated 4E-binding protein 1 in non-small cell lung cancer.
    Lee HW; Lee EH; Lee JH; Kim JE; Kim SH; Kim TG; Hwang SW; Kang KW
    Int J Clin Exp Pathol; 2015; 8(4):3955-62. PubMed ID: 26097581
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of phosphorylated 4E-binding protein 1 and its clinicopathological significances in gastric cancer.
    Lee HW; Park MI; Kim MS; Kim SH; Roh MS; Kim K; Jung SB; Lee EH
    Pathol Res Pract; 2015 Apr; 211(4):298-302. PubMed ID: 25661069
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Twist1-mediated 4E-BP1 regulation through mTOR in non-small cell lung cancer.
    Lv T; Wang Q; Cromie M; Liu H; Tang S; Song Y; Gao W
    Oncotarget; 2015 Oct; 6(32):33006-18. PubMed ID: 26360779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Different roles for the TOS and RAIP motifs of the translational regulator protein 4E-BP1 in the association with raptor and phosphorylation by mTOR in the regulation of cell size.
    Eguchi S; Tokunaga C; Hidayat S; Oshiro N; Yoshino K; Kikkawa U; Yonezawa K
    Genes Cells; 2006 Jul; 11(7):757-66. PubMed ID: 16824195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphorylated 4E-binding protein 1 expression is associated with poor prognosis in small-cell lung cancer.
    Roh MS; Lee JH; Kang KW; Nam HY; Jung SB; Kim K; Lee EH; Park MI; Kim MS; Lee HW
    Virchows Arch; 2015 Dec; 467(6):667-673. PubMed ID: 26445970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of N-terminal region of eIF4E and Ser65-phosphorylation of 4E-BP1 on interaction between eIF4E and 4E-BP1 fragment peptide.
    Tomoo K; Abiko F; Miyagawa H; Kitamura K; Ishida T
    J Biochem; 2006 Aug; 140(2):237-46. PubMed ID: 16825247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of p-Akt, p-mTOR and p-eIF4E proteins associates with metastasis and unfavorable prognosis in non-small cell lung cancer.
    Lu J; Zang H; Zheng H; Zhan Y; Yang Y; Zhang Y; Liu S; Feng J; Wen Q; Long M; Fan S
    PLoS One; 2020; 15(2):e0227768. PubMed ID: 32023262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of 4E-BP1 activity in the mammalian oocyte.
    Jansova D; Koncicka M; Tetkova A; Cerna R; Malik R; Del Llano E; Kubelka M; Susor A
    Cell Cycle; 2017 May; 16(10):927-939. PubMed ID: 28272965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High phosphorylated 4E-binding protein 1 expression after chemoradiotherapy is a predictor for locoregional recurrence and worse survival in esophageal squamous cell carcinoma patients.
    Chao YK; Chuang WY; Yeh CJ; Chang YS; Wu YC; Kuo SY; Hsieh MJ; Hsueh C
    J Surg Oncol; 2012 Mar; 105(3):288-92. PubMed ID: 21932407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of phosphorylated 4E-binding protein 1 predicts lymph node metastasis and poor prognosis of Chinese patients with hilar cholangiocarcinoma.
    Fang Z; Lu L; Tian Z; Luo K
    Med Oncol; 2014 May; 31(5):940. PubMed ID: 24706262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High expression of phosphorylated 4E-binding protein 1 is an adverse prognostic factor in esophageal squamous cell carcinoma.
    Yeh CJ; Chuang WY; Chao YK; Liu YH; Chang YS; Kuo SY; Tseng CK; Chang HK; Hsueh C
    Virchows Arch; 2011 Feb; 458(2):171-8. PubMed ID: 21046149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phosphorylated 4E-BP1 is associated with tumor progression and adverse prognosis in colorectal cancer.
    Chen Y; Wang J; Fan H; Xie J; Xu L; Zhou B
    Neoplasma; 2017; 64(5):787-794. PubMed ID: 28592131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phosphorylated 4E-binding protein 1 (p-4E-BP1): a novel prognostic marker in human astrocytomas.
    Korkolopoulou P; Levidou G; El-Habr EA; Piperi C; Adamopoulos C; Samaras V; Boviatsis E; Thymara I; Trigka EA; Sakellariou S; Kavantzas N; Patsouris E; Saetta AA
    Histopathology; 2012 Aug; 61(2):293-305. PubMed ID: 22690797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 4E binding protein 1 expression is inversely correlated to the progression of gastrointestinal cancers.
    Martín ME; Pérez MI; Redondo C; Alvarez MI; Salinas M; Fando JL
    Int J Biochem Cell Biol; 2000 Jun; 32(6):633-42. PubMed ID: 10785360
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitosis-related phosphorylation of the eukaryotic translation suppressor 4E-BP1 and its interaction with eukaryotic translation initiation factor 4E (eIF4E).
    Sun R; Cheng E; Velásquez C; Chang Y; Moore PS
    J Biol Chem; 2019 Aug; 294(31):11840-11852. PubMed ID: 31201269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of the eukaryotic translation initiation factor 4E (eIF4E) and 4E-BP1 in esophageal cancer.
    Salehi Z; Mashayekhi F
    Clin Biochem; 2006 Apr; 39(4):404-9. PubMed ID: 16375881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of p-4E-BP1 and p-eIF4E on cell proliferation in a breast cancer model.
    Pons B; Peg V; Vázquez-Sánchez MA; López-Vicente L; Argelaguet E; Coch L; Martínez A; Hernández-Losa J; Armengol G; Ramon Y Cajal S
    Int J Oncol; 2011 Nov; 39(5):1337-45. PubMed ID: 21750861
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic significance of expression of eukaryotic initiation factor 4E and 4E binding protein 1 in patients with pathological stage I invasive lung adenocarcinoma.
    Seki N; Takasu T; Sawada S; Nakata M; Nishimura R; Segawa Y; Shibakuki R; Hanafusa T; Eguchi K
    Lung Cancer; 2010 Dec; 70(3):329-34. PubMed ID: 20621385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phosphorylated 4E-BP1 is associated with poor survival in melanoma.
    O'Reilly KE; Warycha M; Davies MA; Rodrik V; Zhou XK; Yee H; Polsky D; Pavlick AC; Rosen N; Bhardwaj N; Mills G; Osman I
    Clin Cancer Res; 2009 Apr; 15(8):2872-8. PubMed ID: 19336517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phosphorylation of 4E-BP1 in the mammalian brain is not altered by LRRK2 expression or pathogenic mutations.
    Trancikova A; Mamais A; Webber PJ; Stafa K; Tsika E; Glauser L; West AB; Bandopadhyay R; Moore DJ
    PLoS One; 2012; 7(10):e47784. PubMed ID: 23082216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.